Anti-inflammatory properties of intracellular insulin-like growth factor binding protein-2 in alveolar epithelial type 2 cells may serve as potential therapeutic strategy for patients with COVID-19, reports a study published in Respiratory Research. ht…
RT @atranscendedman: Phoenix-based researchers studied lung samples from 9 patients and found that loss of IGFBP2 in alveolar type 2 cells…
Phoenix-based researchers studied lung samples from 9 patients and found that loss of IGFBP2 in alveolar type 2 cells worsens inflammation in COVID-19. Restoring IGFBP2 reduced key inflammatory signals, hinting at a new therapeutic path. https://t.co…